EQRx Pronounces Acceptance of Advertising Authorization Utility by the UK’s Medicines and Healthcare Merchandise Regulatory Company for Aumolertinib in EGFR-Mutated Non-small Cell Lung Most cancers
Eqrx, Inc. Advertising authorization software is EQRx’s first submission to a regulatory company Utility is